Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling-Reference-Cited by-同舟云学术

Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling

Published:2013-06-10 Issue:1 Volume:15 Page:
ISSN:1532-429X
Container-title:Journal of Cardiovascular Magnetic Resonance
language:en
Short-container-title:J Cardiovasc Magn Reson

Author:

Tham Edythe B,Haykowsky Mark J,Chow Kelvin,Spavor Maria,Kaneko Sachie,Khoo Nee S,Pagano Joseph J,Mackie Andrew S,Thompson Richard B

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Link

http://link.springer.com/content/pdf/10.1186/1532-429X-15-48.pdf

Reference42 articles.

1. Elbl L, Hrstkova H, Chaloupka V: The late consequences of anthracycline treatment on left ventricular function after treatment for childhood cancer. Eur J Pediatr. 2003, 162 (10): 690-696. 10.1007/s00431-003-1275-y.

2. Marchandise B, Schroeder E, Bosly A, Doyen C, Weynants P, Kremer R, Pouleur H: Early detection of doxorubicin cardiotoxicity: interest of Doppler echocardiographic analysis of left ventricular filling dynamics. Am Heart J. 1989, 118 (1): 92-98. 10.1016/0002-8703(89)90077-X.

3. Ewer MS, Ali MK, Mackay B, Wallace S, Valdivieso M, Legha SS, Benjamin RS, Haynie TP: A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving Adriamycin. J Clin Oncol. 1984, 2: 112-117.

4. Steinherz LJ, Steinherz PG, Tan CT, Heller G, Murphy ML: Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA. 1991, 266 (12): 1672-1677. 10.1001/jama.1991.03470120074036.

5. Shankar SM, Marina N, Hudson MM, Hodgson DC, Adams MJ, Landier W, Bhatia S, Meeske K, Chen MH, Kinahan KE, Steinberger J, Rosenthal D, 2: Monitoring for cardiovascular disease in survivors of childhood cancer: report from the cardiovascular disease task force of the Children’s oncology group. Pediatrics. 2008, 121: e387-e396. 10.1542/peds.2007-0575. Epub 2008 Jan 10

Cited by 194 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric Cardio-Oncology: Screening, Risk Stratification, and Prevention of Cardiotoxicity Associated with Anthracyclines;Children;2024-07-22

2. T1 Mapping in Cardiovascular Magnetic Resonance—A Marker of Diffuse Myocardial Fibrosis in Patients Undergoing Hematopoietic Stem Cell Transplantation;Journal of Personalized Medicine;2024-04-13

3. The Significance of Parametric Mapping in Advanced Cardiac Imaging;Cardiology in Review;2024-04-08

4. Myocardial extracellular volume derived from contrast-enhanced chest computed tomography in longitudinal evaluation of cardiac toxicity in patients treated with immune checkpoint inhibitors;Quantitative Imaging in Medicine and Surgery;2024-04

5. Anthracycline‐induced cardiotoxicity on regional myocardial work and left ventricular mechanical dispersion in adolescents and young adults in post‐lymphoma remission;Cancer Medicine;2024-01-10